Karl Utermohlen

By Karl Utermohlen, InvestorPlace Writer Jun 24, 2019

Presidential candidate Bernie Sanders' student loans proposal promises to cancel the $1.6 trillion student loan debt that exists in the U.S.

By Karl Utermohlen, InvestorPlace Writer Jun 24, 2019

In recent Krystal Biotech news, KRYS stock is soaring as the company's drug designed to treat a skin condition received expedited FDA review.

By Karl Utermohlen, InvestorPlace Writer Jun 24, 2019

In the latest Minerva Neurosciences news, NERV stock is skyrocketing as the company's insomnia treatment trial yielded positive results.

By Karl Utermohlen, InvestorPlace Writer Jun 24, 2019

A women's libido drug has been developed by AMAG Pharmaceuticals and the FDA has now approved it for women who experience low sexual drive.

By Karl Utermohlen, InvestorPlace Writer Jun 24, 2019

In the latest Kraft Heinz news, KHC stock is down more than 2% Monday as a Guggenheim Securities analyst noted that the brand is low on cash.

By Karl Utermohlen, InvestorPlace Writer Jun 24, 2019

The FUCT clothing brand won a ruling regarding its right to trademark its name, which had previously been deemed by some to be "scandalous."

By Karl Utermohlen, InvestorPlace Writer Jun 21, 2019

A Shake Shack 4-day work week is being tested in Las Vegas and the West Coast with the hopes that it'll keep employees happy and healthy.

By Karl Utermohlen, InvestorPlace Writer Jun 21, 2019

Traces of arsenic in bottled water have been found, which is a toxin that may cause cancer if consumed. Here's what you should know about it.

By Karl Utermohlen, InvestorPlace Writer Jun 21, 2019

In the most recent SeaWorld news, the company received an upgrade from Goldman Sachs and other analysts, lifting SEAS stock more than 3%.

By Karl Utermohlen, InvestorPlace Writer Jun 21, 2019

In the latest Axovant Gene Therapies news, the company inked a deal with Yposeski regarding the manufacturing of its experimental treatment.

Recent Articles